# SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE
> **ANDA202365** · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS INC · Approved 2015-10-30
## Drug
- **FDA Application Number:** ANDA202365
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE
- **Generic name:** Sitagliptin Phosphate
- **Active ingredients:** SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** WATSON LABS INC
- **First approval:** 2015-10-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202365)
---
*AI Analytics · CC0 1.0*